Details for New Drug Application (NDA): 020209
✉ Email this page to a colleague
NDA 020209 describes OXISTAT, which is a drug marketed by Fougera Pharms and Ani Pharms and is included in two NDAs. It is available from two suppliers. Additional details are available on the OXISTAT profile page.
The generic ingredient in OXISTAT is oxiconazole nitrate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the oxiconazole nitrate profile page.
The generic ingredient in OXISTAT is oxiconazole nitrate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the oxiconazole nitrate profile page.
Summary for 020209
| Tradename: | OXISTAT |
| Applicant: | Ani Pharms |
| Ingredient: | oxiconazole nitrate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 020209
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OXISTAT | oxiconazole nitrate | LOTION;TOPICAL | 020209 | NDA | ANI Pharmaceuticals, Inc. | 62559-285 | 62559-285-06 | 6 BOTTLE in 1 CARTON (62559-285-06) / 7 mL in 1 BOTTLE |
| OXISTAT | oxiconazole nitrate | LOTION;TOPICAL | 020209 | NDA | ANI Pharmaceuticals, Inc. | 62559-285 | 62559-285-30 | 1 BOTTLE in 1 CARTON (62559-285-30) / 30 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | EQ 1% BASE | ||||
| Approval Date: | Sep 30, 1992 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
